NO993407L - Preparation of protein preparations with reduced aggregate content - Google Patents
Preparation of protein preparations with reduced aggregate contentInfo
- Publication number
- NO993407L NO993407L NO993407A NO993407A NO993407L NO 993407 L NO993407 L NO 993407L NO 993407 A NO993407 A NO 993407A NO 993407 A NO993407 A NO 993407A NO 993407 L NO993407 L NO 993407L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- aggregate content
- protein preparations
- reduced aggregate
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Oppfinnelsen angår en fremgangsmåte for fremstilling av proteinpreparater med redusert aggregatinnhold, særlig fremstilling av medisinske preparater fra blodplasmaprotein som f.eks. albumin.BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a process for the preparation of protein preparations having a reduced aggregate content, in particular to the preparation of medical preparations from blood plasma protein, e.g. albumin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998131061 DE19831061A1 (en) | 1998-07-10 | 1998-07-10 | Reducing aggregate content of protein preparation, especially virus-inactivated therapeutic plasma protein or chemically modified protein preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993407D0 NO993407D0 (en) | 1999-07-09 |
NO993407L true NO993407L (en) | 2000-01-11 |
Family
ID=7873695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993407A NO993407L (en) | 1998-07-10 | 1999-07-09 | Preparation of protein preparations with reduced aggregate content |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0976759A3 (en) |
JP (1) | JP2000053581A (en) |
AU (1) | AU3676599A (en) |
CA (1) | CA2277406A1 (en) |
DE (1) | DE19831061A1 (en) |
NO (1) | NO993407L (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6365395B1 (en) * | 2000-11-03 | 2002-04-02 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
AU2004228847B2 (en) * | 2003-04-09 | 2010-06-17 | Km Biologics Co., Ltd. | Process for producing albumin preparation |
JP2006182649A (en) * | 2003-04-09 | 2006-07-13 | Chemo Sero Therapeut Res Inst | Method for removing albumin aggregate and/or contaminated protein |
EP1722834B1 (en) | 2003-12-22 | 2012-06-27 | Regentis Biomaterials Ltd. | Matrix comprising naturally-occurring crosslinked protein backbone |
US7842667B2 (en) | 2003-12-22 | 2010-11-30 | Regentis Biomaterials Ltd. | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
ES2294976B1 (en) * | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "HIGH EFFECTIVE HUMAN ALBUMIN OBTAINING PROCEDURE FOR USE IN DETOXIFICATION THERAPY". |
WO2017084682A1 (en) | 2015-11-20 | 2017-05-26 | Hepa Wash Gmbh | Method for extracorporeal carbon dioxide removal |
WO2017084683A1 (en) | 2015-11-20 | 2017-05-26 | Hepa Wash Gmbh | Method for extracorporeal lung support |
PL3429657T3 (en) | 2016-03-14 | 2022-08-22 | Advitos Gmbh | Systems or apparatuses for performing dialysis |
US20210100941A1 (en) * | 2017-03-28 | 2021-04-08 | Advitos Gmbh | Compositions and methods for regenerating carrier protein-containing multiple pass albumin dialysis fluid |
JP7213556B2 (en) | 2017-05-22 | 2023-01-27 | アドビトス ゲーエムベーハー | Method and system for removing carbon dioxide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4156681A (en) * | 1974-03-28 | 1979-05-29 | Plasmesco Ag | Process for isolating albumin from blood |
DE3641115A1 (en) * | 1986-12-02 | 1988-06-16 | Lentia Gmbh | METHOD FOR PRODUCING AN INTRAVENOUS APPLICABLE AND STABLE IN LIQUID FORM IMMUNOGLOBULINS |
FR2648048B1 (en) * | 1989-06-08 | 1994-06-03 | Lille Transfusion Sanguine | PROCESS FOR THE PREPARATION OF PURIFIED ALBUMIN SOLUTIONS |
US5440018A (en) * | 1992-05-20 | 1995-08-08 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
-
1998
- 1998-07-10 DE DE1998131061 patent/DE19831061A1/en not_active Withdrawn
-
1999
- 1999-06-28 AU AU36765/99A patent/AU3676599A/en not_active Abandoned
- 1999-07-08 CA CA 2277406 patent/CA2277406A1/en not_active Abandoned
- 1999-07-09 EP EP99113359A patent/EP0976759A3/en not_active Withdrawn
- 1999-07-09 NO NO993407A patent/NO993407L/en unknown
- 1999-07-12 JP JP11197459A patent/JP2000053581A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2277406A1 (en) | 2000-01-10 |
EP0976759A3 (en) | 2002-08-14 |
NO993407D0 (en) | 1999-07-09 |
JP2000053581A (en) | 2000-02-22 |
DE19831061A1 (en) | 2000-01-13 |
AU3676599A (en) | 2000-06-22 |
EP0976759A2 (en) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1200418T3 (en) | Nematodicidal trifluorobutene | |
BG101118A (en) | Therapeutical compounds | |
FI20011109A (en) | Bis-indolylsuccinimide derivatives and their preparation | |
NO20030374L (en) | Cyclopentanoindoles, preparations containing such compounds and treatment methods | |
NO954320L (en) | Lyospheres comprising gonadotropin | |
EA199901031A1 (en) | Derivatives of benzimidazole | |
AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
ATE231872T1 (en) | THIAZOLOPYRIMIDE DERIVATIVES | |
EE200200208A (en) | Oligosaccharides, process for their preparation and use, and pharmaceutical compositions | |
NO993407L (en) | Preparation of protein preparations with reduced aggregate content | |
ES2160410T3 (en) | IMMUNOTOLERANT PROTROMBINE COMPLEX PREPARATIONS. | |
IT1293778B1 (en) | 1,4,7,10-TETRAAZABICICLO (8.2.2.)TETRADECAN-2 ONE, ITS PREPARATION AND USE FOR THE PREPARATION OF TETRAAZAMACROCYCLES | |
UA35639C2 (en) | Method for obtaining of composition of purified core protein of human papilloma virus. | |
CA2531419C (en) | Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment | |
PT1107793E (en) | DEXTRANE-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND RELATED PROCESSES | |
BR9915460A (en) | Method of treatment of viral hemorrhagic fever | |
MXPA03007992A (en) | Pharmaceutical composition of f(ab)2. | |
EA199700243A1 (en) | AMINOTHETRALINE DERIVATIVE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
BR0211991A (en) | Modified Human Growth Hormone | |
MD1473G2 (en) | Antiherpetic remedy | |
PT1408035E (en) | METHOD FOR THE PREPARATION OF DERIVATIVES OF 1,5-DIARIL-3-TRIFLUOROMETHYL-DELTA2-PYRAZOLINS THAT ARE RACERICALLY AND ENHANCERLY PURE | |
BR0011559A (en) | Process for the preparation of benzosuberan 10, 11-methane derivatives | |
AU6290398A (en) | Inclusion complexes in aqueous solution | |
CY1106306T1 (en) | 5-IMINO-13-DEOXY ANTHRACYCLINE DERIVATIVES, THEIR USES AND PROCESSES FOR THEIR PREPARATION | |
ATE329898T1 (en) | COMBINATION PREPARATION FOR THE THERAPY OF IMMUNOLOGICAL DISEASES |